Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the timescale is for NHS England to expand access to routine genomic profiling for eligible cancer patients with metastatic/locally-advanced disease.

In the NHS Long Term Plan, NHS England and NHS Improvement outlined the commitment to offer more extensive genomic testing to patients who are newly diagnosed with cancers so that by 2023 over 100,000 people a year can access these tests.

A range of genomic testing for patients with cancer covering both adult and paediatric solid and haematological cancers is already available through the NHS Genomic Medicine Service as outlined in the National Genomic Test Directory.